IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.315
EU - Europa 7.457
AS - Asia 6.603
SA - Sud America 3.425
AF - Africa 389
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 4
Totale 28.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.110
BR - Brasile 2.731
VN - Vietnam 2.047
SG - Singapore 1.902
UA - Ucraina 1.665
RU - Federazione Russa 1.575
IE - Irlanda 821
DE - Germania 757
DK - Danimarca 627
HK - Hong Kong 594
SE - Svezia 526
CN - Cina 468
IT - Italia 455
TR - Turchia 453
FI - Finlandia 397
KR - Corea 328
FR - Francia 321
AR - Argentina 273
MA - Marocco 146
GB - Regno Unito 136
BD - Bangladesh 132
IN - India 129
ID - Indonesia 126
EC - Ecuador 121
IQ - Iraq 98
CO - Colombia 91
MX - Messico 88
ZA - Sudafrica 78
PY - Paraguay 57
CA - Canada 56
PK - Pakistan 54
EU - Europa 47
VE - Venezuela 45
AT - Austria 40
CL - Cile 36
PE - Perù 34
TN - Tunisia 34
CI - Costa d'Avorio 33
PH - Filippine 31
JP - Giappone 27
UY - Uruguay 26
UZ - Uzbekistan 26
EG - Egitto 24
PL - Polonia 24
DZ - Algeria 21
KE - Kenya 21
JO - Giordania 20
AE - Emirati Arabi Uniti 19
NL - Olanda 19
KZ - Kazakistan 17
ES - Italia 15
TH - Thailandia 15
AL - Albania 14
SA - Arabia Saudita 13
BE - Belgio 12
BO - Bolivia 11
DO - Repubblica Dominicana 11
MY - Malesia 11
JM - Giamaica 10
LB - Libano 10
OM - Oman 10
BY - Bielorussia 9
NP - Nepal 9
AZ - Azerbaigian 8
BG - Bulgaria 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
GT - Guatemala 6
KG - Kirghizistan 6
PA - Panama 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
HN - Honduras 5
IL - Israele 5
AU - Australia 4
BH - Bahrain 4
ET - Etiopia 4
GE - Georgia 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
BW - Botswana 3
GN - Guinea 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
LV - Lettonia 3
RO - Romania 3
SV - El Salvador 3
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
IR - Iran 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
Totale 28.214
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.629
Fairfield 1.006
Singapore 971
Ashburn 912
Dublin 819
Ho Chi Minh City 697
Boardman 661
Hong Kong 588
Wilmington 494
Dallas 477
Hanoi 427
Woodbridge 406
Houston 382
Seattle 352
San Mateo 330
Lawrence 328
Princeton 328
Chandler 305
San Jose 292
Cambridge 288
Lauterbourg 285
Centro 277
Moscow 247
The Dalles 220
São Paulo 214
New York 180
Ann Arbor 164
San Diego 136
Des Moines 134
Hefei 127
Da Nang 99
Beijing 89
Los Angeles 88
Rio de Janeiro 86
Haiphong 83
Curitiba 56
Helsinki 55
Brasília 48
Porto Alegre 48
Belo Horizonte 45
Chicago 42
Guayaquil 42
Nuremberg 41
Biên Hòa 38
Quito 35
Thái Bình 34
Abidjan 33
Munich 33
Saint Petersburg 33
Salvador 33
London 32
Baghdad 31
Campinas 30
Ribeirão Preto 30
Orem 29
Hải Dương 28
Council Bluffs 27
Johannesburg 26
São Bernardo do Campo 24
Guarulhos 23
Phủ Lý 23
Sorocaba 23
Tashkent 23
Thái Nguyên 23
Can Tho 22
Dhaka 22
Asunción 21
Lima 21
Ninh Bình 21
Norwalk 21
Shanghai 21
Turku 21
Buenos Aires 20
Guangzhou 20
Manaus 20
Warsaw 20
Brooklyn 19
Goiânia 19
Vienna 19
Amman 18
Cape Town 18
Jakarta 18
Nairobi 18
Bắc Ninh 17
Denver 17
Fortaleza 17
Santa Clara 17
Santo André 17
Bogotá 16
Buffalo 16
Chennai 16
Duque de Caxias 16
Medellín 16
Nova Iguaçu 16
Osasco 16
Salt Lake City 16
Tokyo 16
Bắc Giang 15
Ha Long 15
Ipatinga 15
Totale 15.762
Salva come PNG Salva come JPEG
Nome #
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 167
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 165
[Closed surgical treatment in acute severe pancreatitis] 160
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 157
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 149
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 142
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 140
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 140
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 137
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 135
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 134
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 131
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 131
Ultrasonography of the pancreas. 7. Intraoperative imaging. 128
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study. 127
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 127
Enhanced recovery pathways in pancreatic surgery: State of the art 127
Italian consensus guidelines for chronic pancreatitis 125
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 125
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 125
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 124
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 124
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 123
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 122
B-Cell Lymphoma Presenting as Acute Pancreatitis. 122
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 119
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 119
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 118
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 117
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 116
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 116
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 115
A preoperative score to predict early death after pancreatic cancer resection 115
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 114
A systematic review on robotic pancreaticoduodenectomy. 112
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 111
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 110
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 110
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 109
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 109
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 107
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 107
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 105
Neuroendocrine Tumor Disease- An Evolving Landscape. 104
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 104
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 104
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 104
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 101
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 101
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 101
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 101
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 101
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 101
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 100
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 99
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 99
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 99
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 99
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 98
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis 98
Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications 98
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 98
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 98
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 98
Pancreas: Insulinoma--new insights into an old disease. 97
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 97
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 97
Pancreatoblastoma in adults: a review of the literature. 97
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 97
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 97
Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma. 96
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. 96
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 96
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 96
Allelotype of pancreatic acinar cell carcinoma. 96
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 96
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 95
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 95
Cisti splenica epiteliale 95
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 95
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 95
Current status of robotic distal pancreatectomy: a systematic review. 94
Anastomotic leakage in pancreatic surgery. 94
Identification of a novel antibody associated with autoimmune pancreatitis 93
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 93
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. 93
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 93
Well-differentiated pancreatic nonfunctioning tumors/carcinoma 93
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 93
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 93
In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas 92
La chemioterapia loco-egionale migliora la sopravvivenza dei pazienti affetti da adenocarcinoma pancreatico non resecabile? Risultati di uno studio aperto, controllato 92
Extent of surgical resections for intraductal papillary mucinous neoplasms. 92
Questions about branch-duct IPMNs with Sendai negative criteria. 92
Rectal indomethacin to prevent post-ERCP pancreatitis. 91
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 91
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression 91
Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses 90
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 90
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 90
Totale 10.905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021946 0 0 0 0 0 0 0 0 0 331 400 215
2021/20222.074 123 565 12 93 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/202610.711 498 1.145 1.202 2.765 358 451 1.719 1.136 681 756 0 0
Totale 28.309